Matthew Maurer

110PUBLICATIONS
422CO-AUTHORS
Predictive and prognostic markersDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (110)

|Aug 04, 2026
Risk of Bias Associated with Varying Sampling Strategies for External Comparator Cohorts for Single-Arm Trials: Insights from Aggressive Lymphoma.

|Jun 24, 2026
No association of prior administration of selected vaccines with lymphoma prognosis.

|Jun 04, 2026
Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.

|Apr 25, 2026
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

|Apr 14, 2026
Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy.

Prokop Vodička, Tarec C El-Galaly, Vit Prochazka

|Apr 14, 2026
Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs

Pageof 19

Frequent Collaborators

57 joint publications

James R Cerhan

26 joint publications

Yucai Wang

26 joint publications

Andrew L Feldman

24 joint publications

Thomas E Witzig